Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Share-based Compensation (2019 - 2026)

Biodesix filings provide 8 years of Share-based Compensation readings, the most recent being $1.1 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 14.71% to $1.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $4.3 million, a 13.84% decrease, with the full-year FY2025 number at $4.1 million, down 37.65% from a year prior.
  • Share-based Compensation hit $1.1 million in Q1 2026 for Biodesix, up from $1.1 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $2.6 million in Q1 2024 to a low of $954000.0 in Q3 2023.
  • Median Share-based Compensation over the past 5 years was $1.2 million (2022), compared with a mean of $1.4 million.
  • Biggest five-year swings in Share-based Compensation: surged 153.8% in 2022 and later tumbled 63.18% in 2025.
  • Biodesix's Share-based Compensation stood at $2.1 million in 2022, then crashed by 47.95% to $1.1 million in 2023, then increased by 17.02% to $1.3 million in 2024, then fell by 15.02% to $1.1 million in 2025, then increased by 3.72% to $1.1 million in 2026.
  • The last three reported values for Share-based Compensation were $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025) per Business Quant data.